Clinical Trial Update: A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis [NA]

View source ↗

Summary

A randomized double-blind trial compares ceftazidime and meropenem for severe melioidosis, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melioidosis

Drugs mentioned

• Meropenem (Meropenem)
• ceftazidime (ceftazidime)

Snippet

Sponsor: University of Oxford | Conditions: Melioidosis | NA | Status: UNKNOWN